AEGIRBIO ABAEGIRBIO ABAEGIRBIO AB

AEGIRBIO AB

No trades
See on Supercharts
Market capitalization
‪17.26 M‬SEK
−3.960SEK
‪−362.83 M‬SEK
‪1.71 M‬SEK
‪17.72 M‬
Beta (1Y)
0.72

About AEGIRBIO AB

CEO
Marco Witteveen
Headquarters
Lund
Founded
2019
ISIN
SE0014401121
FIGI
BBG00V762R99
AegirBio AB engages in the development and commercialization of drug monitoring tests. Its products include Viraspec COVID-19 Saliva Test and moNATor. The company was founded on September 26, 2019 and is headquartered in Lund, Sweden.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of AEGIR is 0.501 SEK — it has decreased by 7.22% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange AEGIRBIO AB stocks are traded under the ticker AEGIR.
AEGIR stock is 17.76% volatile and has beta coefficient of 0.72. Check out the list of the most volatile stocks — is AEGIRBIO AB there?
Yes, you can track AEGIRBIO AB financials in yearly and quarterly reports right on TradingView.
AEGIR stock has fallen by 26.22% compared to the previous week, the month change is a 31.84% fall, over the last year AEGIRBIO AB has showed a 75.20% decrease.
AEGIR net income for the last quarter is ‪−17.94 M‬ SEK, while the quarter before that showed ‪−16.00 M‬ SEK of net income which accounts for −12.11% change. Track more AEGIRBIO AB financial stats to get the full picture.
Today AEGIRBIO AB has the market capitalization of ‪16.67 M‬, it has decreased by 3.39% over the last week.
No, AEGIR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, AEGIR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AEGIRBIO AB stock right from TradingView charts — choose your broker and connect to your account.
AEGIR reached its all-time high on Jul 27, 2021 with the price of 399.500 SEK, and its all-time low was 0.500 SEK and was reached on Mar 5, 2024.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AEGIRBIO AB technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AEGIRBIO AB stock shows the sell signal. See more of AEGIRBIO AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.